Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07943325
PHASE3

Delayed Application of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Sponsor: Goethe University

View on ClinicalTrials.gov

Summary

This study is a multicenter, randomized, open-label phase 3 trial of delayed administration of immunotherapy in patients who are planned to receive chemoimmunotherapy for newly diagnosed, advanced or metastatic, PD-L1 positive NSCLC without sensitizing alterations in EGFR, ALK, or ROS1.

Official title: Delayed Application of Immune Checkpoint Inhibitors in Patients With Advanced or Metastatic NSCLC Receiving Chemoimmunotherapy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

198

Start Date

2027-02

Completion Date

2032-02

Last Updated

2026-11-17

Healthy Volunteers

No

Interventions

DRUG

Cisplatin

Dose per standard-of-care

DRUG

Carboplatin

Dose per standard-of-care

DRUG

Pemetrexed

Dose per standard-of-care

DRUG

Paclitaxel

Dose per standard-of-care

DRUG

Cemiplimab

Dose per standard-of-care

Locations (1)

Universitätsmedizin Frankfurt

Frankfurt am Main, Hesse, Germany